| Revista: | Brazilian Journal of Pharmaceutical Sciences |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000451872 |
| ISSN: | 1984-8250 |
| Autores: | Ali, Mohammad Daud1 Ahmad, Ayaz1 Banu, Nuzhat1 Patel, Munfis2 Ghosn, Sherihan Ahmad1 Eltrafi, Zainab1 |
| Instituciones: | 1Mohammed Al-Mana College for Medical Sciences, Department of Pharmacy, Al Safa, Dammam. Saudi Arabia 2Mohammed Al-Mana College for Medical Sciences, Foundation Year Department, Al Safa, Dammam. Saudi Arabia |
| Año: | 2022 |
| Volumen: | 58 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Analítico, descriptivo |
| Resumen en inglés | Diabetic mellitus is an emerging disease in Saudi Arabia. In this regard, a cross-sectional retrospective study was conducted to evaluate drug utilization pattern and the cost associated with non-insulin-dependent diabetes mellitus disease management in Saudi Arabia. Data retrieved from the electronic pharmacy records during the last one year were employed in this study. World Health Organization (WHO) Defined Daily Dose (DDD) method was employed to compute the daily price of each oral hypoglycaemic agent. The American Diabetes Association (ADA) guidelines and protocols were used to evaluate the level of adherence. A total of 17057 patients were enrolled in the study. Out of the 17057 patients enrolled in the study, 60.06 % (10246) were males and the rest females. In monotherapy, biguanides (metformin) were the most recommended and utilised drugs among 5673 patients (33.25%). The most commonly used drug combination was found to be sitagliptin+metformin (1754 units). The cost per unit dose was highest for liraglutide (A10BJ02) 258.32SR (68.79USD), and lowest for metformin (A10BA02) 0.49SR (0.13 USD). Metformin was the choice drug for the diabetes patients; biguanides (metformin) and DPP-4 (sitagliptins) were the most familiar established dose combination employed. Generic drugs should be used in order to reduce overall cost |
| Disciplinas: | Medicina |
| Palabras clave: | Endocrinología, Farmacología, Salud pública, Diabetes mellitus tipo 2, Hipoglucemiantes, Patrones de consumo, Análisis de costos |
| Keyword: | Endocrinology, Pharmacology, Public health, Diabetes mellitus type 2, Hypoglycemic agents, Consumption patterns, Cost analysis |
| Texto completo: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
